Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
440
datasets available to search
ShareScore release 0.9.0
Dataset results
440 results for “Dapagliflozin”
A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone
ClinicalTrials.gov study NCT00528879. IPD Sharing: Not stated. Countries: 5. Publications: 7.
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
ClinicalTrials.gov study NCT02725593. IPD Sharing: YES. Countries: 7. Publications: 1.
Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT00855166. IPD Sharing: Not stated. Countries: 5. Publications: 4.
Dapagliflozin for Cardio-renal Protection After ICU Discharge
ClinicalTrials.gov study NCT07025629. IPD Sharing: YES. Countries: 1. Publications: 8.
An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin
ClinicalTrials.gov study NCT02433678. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
ClinicalTrials.gov study NCT03619213. IPD Sharing: YES. Countries: 20. Publications: 48.
Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea
ClinicalTrials.gov study NCT01392677. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Does Dapagliflozin Augment The Favorable Adaptation To Endurance Exercise Training?
ClinicalTrials.gov study NCT02371187. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
ClinicalTrials.gov study NCT03036150. IPD Sharing: NO. Countries: 21. Publications: 32.
Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin
ClinicalTrials.gov study NCT02429258. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Outcomes of Dapagliflozin in Acute Heart Failure With Reduced Ejection Fraction (CODA-HFrEF)
ClinicalTrials.gov study NCT06012279. IPD Sharing: YES. Countries: 1. Publications: 3.
Dapagliflozin And Pulmonary Artery Hemodynamics in Heart Failure With Reduced Ejection Fraction Patients With CardioMEMS®
ClinicalTrials.gov study NCT04570865. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of the Tubular Effects of Dapagliflozin Using 1HNMR Spectroscopy
ClinicalTrials.gov study NCT02798757. IPD Sharing: NO. Countries: 1. Publications: 2.
Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
ClinicalTrials.gov study NCT02304081. IPD Sharing: Not stated. Countries: 1. Publications: 13.
Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
ClinicalTrials.gov study NCT04356742. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.
ClinicalTrials.gov study NCT03007329. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial to Investigate the Effect of Dapagliflozin on Ischemia Reperfusion Induced Endothelial Dysfunction
ClinicalTrials.gov study NCT05217654. IPD Sharing: NO. Countries: 1. Publications: 18.
Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF
ClinicalTrials.gov study NCT03794518. IPD Sharing: NO. Countries: 1. Publications: 16.
Dapagliflozin With or Without Spironolactone for HFpEF
ClinicalTrials.gov study NCT05676684. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)
ClinicalTrials.gov study NCT02577159. IPD Sharing: Not stated. Countries: 1. Publications: 9.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.